查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2000387

藥匣市場：市場規模、佔有率、成長和行業分析（按材料、尺寸和應用分類），至2034年的區域預測

Cartridges Market, Size, Share, Growth, and Industry Analysis, By Material Type (Glass and Plastic), By Size (1ml to 5ml, 5ml to 15ml and 15ml to 30ml), By Application (Diabetes and Others), Regional Forecast to 2034
出版日期: | 出版商: Prismane Consulting | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球藥匣市場

受慢性病和急性病治療領域對預填充即用型給藥系統需求不斷成長的推動，全球藥匣市場預計將在2025年至2034年間以7.1%的年複合成長率成長。藥匣通常用於筆式注射器和自動注射器，在確保劑量精準、無菌和患者便利性方面發揮著非常重要的作用。隨著糖尿病等慢性病盛行率的上升以及生物製藥自我給藥方式的普及，藥匣正成為現代給藥系統的重要組成部分。該市場的特點是材料工程、精密成型和製藥級製造技術的進步，以滿足嚴格的監管要求和不斷發展的以患者為中心的醫療保健模式。

依材料類型分類的需求

從材料類型來看，市場區隔將注射劑筒分為玻璃和塑膠兩大類。玻璃注射劑筒因其優異的耐化學性、卓越的阻隔性以及與多種注射藥物的相容性而佔據主導地位。特別是硼矽酸玻璃，因其穩定性高且萃取率低，成為胰島素和生物製藥的理想選擇。然而，在需要輕量化設計、更高抗破損性和成本效益的應用領域，塑膠注射筒正日益受到關注。高性能環烯烴聚合物（COP）和環烯烴共聚物（COCs）的開發拓展塑膠注射劑筒在先進藥物輸送系統中的應用範圍。隨著製藥公司在器械設計和患者便利性方面不斷追求差異化，預計未來幾年塑膠注射劑筒的應用將加速成長。

尺寸需求

從容量大小來看，藥匣市場可分為1ml-5ml、5ml-15ml及15ml-30ml三個細分市場。其中，1ml-5ml細分市場佔據較大佔有率，這主要歸功於其在胰島素筆和其他皮下注射療法中的廣泛應用。這些緊湊型的藥匣最佳化了給藥的精準性，並提升了患者的便利性，使其非常適合用於糖尿病和其他慢性疾病的治療。隨著生物製藥和需要中等劑量的特藥的日益普及，5ml-15ml細分市場的發展動力強勁。同時，15ml-30ml細分市場預計將在特殊治療以及特定的獸醫和醫院應用中擁有一定的市場需求。隨著生物製藥和聯合治療在藥物研發管線中佔據越來越重要的地位，預計各種容量的藥匣需求將保持強勁。

應用需求

從應用領域來看，糖尿病在全球藥匣市場佔最大佔有率。糖尿病在全球日益加重，尤其是在新興經濟體，這推動了對胰島素輸注系統的需求，包括可重複使用和拋棄式胰島素筆。與傳統的管瓶和注射器相比，基於藥匣的胰島素筆系統具有便利性、精確性和患者依從性高等優點，使其成為更受歡迎的選擇。 「其他」領域，包括荷爾蒙療法、生育治療和生物製藥，也在快速成長。隨著許多注射藥物轉向自我給藥形式，藥匣有望在注射藥物生態系統中佔據更大的佔有率。

市場促進因素

全球藥匣市場的主要促進因素是全球糖尿病患者數量的不斷成長以及胰島素筆式給藥系統日益普及。隨著醫療保健系統越來越重視居家照護和提高病患的用藥依從性，整合式藥匣在安全性、準確性和便利性方面展現出極具吸引力的提案。

市場限制因素

一個主要的限制因素是與藥品包裝組件相關的嚴格法規和品質合規要求。生產藥匣需要對無塵室設施、先進的檢測系統和驗證流程進行大量資本投入，這可能會限制市場准入，並給中小型製造商帶來價格壓力。

區域需求

北美仍然是主要市場，這得益於其高糖尿病盛行率、先進的醫療保健基礎設施以及自行注射裝置的廣泛應用。大型製藥企業的存在和嚴格的監管標準進一步推動了對高品質、合規的注射劑盒系統的需求。歐洲緊隨其後，其強勁的需求得益於成熟的製藥製造地以及對病患安全和器械創新的高度重視。德國和瑞士等國是玻璃和特殊包裝產品的主要生產中心。

亞太地區正崛起為成長最快的地區，這主要得益於糖尿病患者數量的快速成長、醫療保健服務的改善以及藥品生產能力的提升。中國和印度等國加大對注射劑生產的投資，推高了對玻璃和塑膠注射藥匣的需求。此外，具有成本競爭力的生產能力和不斷擴大的出口活動也鞏固了該地區在全球供應鏈中的地位。

主要製造商

市場上的主要企業包括Stevanato group、Nipro corporation、Gerreshimer AG、West Pharmaceutical services Inc.、Schott AG、Transcoject GmbH、Shandong Medicinal Glass Co ltd、Datwlyer Holding Inc、Aptar Group Inc、Sonata Rubber等。

總體而言，受材料創新、慢性病患病率上升以及注射藥物輸送方式向以患者為中心的解決方案不斷轉變的推動，全球注射劑市場預計將穩步擴張。

目錄

第1章 引言

第2章 市場概覽

  • 市場演變
  • 需求概覽
  • 產業結構
  • 戰略挑戰
  • 終端用戶趨勢
  • 成長預測

第3章 經濟與能源展望

  • 國內生產毛額和人口統計資料
  • 貨幣/財政政策

第4章 藥匣概述和市場概覽

  • 產品描述
  • 等級和特性
  • 原料
  • 製造過程
  • 環境問題
  • 價值鏈
  • 目的

第5章 市場動態與產業趨勢

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 課題

第6章 全球藥匣需求分析（依材料類型、尺寸和應用）（價值）（2018-2034年）

  • 戰略挑戰及新冠疫情的影響
  • 需求分析與預測（2018-2034）
    • 需求
    • 需求成長率（%）
    • 推進分析
    • 其他功能性成分
  • 全球藥匣市場（依材料類型）
    • 玻璃
    • 塑膠
  • 全球藥匣市場（依尺寸）
    • 1ml～5ml
    • 5ml～15ml
    • 15ml～30ml
  • 全球藥匣市場（依應用領域）
    • 糖尿病
    • 其他

第7章 需求分析與市場概覽（依地區和國家）（價值）（2018-2034年）

  • 戰略挑戰及新冠疫情的影響
  • 需求分析與預測（2018-2034）
  • 需求成長率（%）
  • 藥匣市場（依材質類型）
  • 藥匣市場（依尺寸）
  • 藥匣市場（依應用領域）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 西歐
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 其他
  • 中歐/東歐
    • 俄羅斯
    • 波蘭
    • 土耳其
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • ASEAN
    • 其他
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 中東
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 非洲
    • 南非
    • 其他

第8章 價格分析

第9章 關鍵策略挑戰與商業機會評估

  • 市場吸引力評估
  • 未來前景及目標市場研究

第10章 戰略建議與提案

第11章 公司分析與市場佔有率分析

  • 藥匣製造商公司簡介/公司分析
    • 基本資料
    • 總部、主要市場
    • 所有權
    • 公司財務
    • 製造地
    • 全球銷售
    • 員工總數
    • 產品系列/服務/解決方案
    • Prismane Consulting 的關鍵商務策略及概況
    • 近期趨勢
    • 目標公司

第12章 註：本部分包含企業資料、財務報表、製造地和營運區域。財務報表僅收錄於已向美國證券交易委員會（SEC）提交的文件、年度報告或公司網站上公佈的公司。本報告中所包含的所有財務報表均以美元計價。以其他貨幣計價的財務報表已使用平均外匯換算。公司簡介可能包含製造商、供應商和經銷商。

第13章 附錄

簡介目錄

Global Cartridges Market

The global cartridges market is expected to witness a CAGR of 7.1% between 2025-2034, driven by the rising demand for prefillable and ready-to-use drug delivery systems across chronic and acute therapeutic segments. Cartridges, typically used in pen injectors and autoinjectors, play a critical role in ensuring accurate dosing, sterility, and patient convenience. With the increasing prevalence of chronic diseases such as diabetes and the shift toward self-administration of biology, cartridges have emerged as an integral component of modern drug delivery. The market is characterized by advancements in material engineering, precision molding, and pharmaceutical-grade manufacturing, aligning with stringent regulatory requirements and evolving patient-centric healthcare models.

Demand by Material Type

By material type, the market is segmented into glass and plastic cartridges. Glass cartridges continue to dominate due to their superior chemical resistance, excellent barrier properties, and compatibility with a wide range of injectable drugs. Borosilicate glass, in particular, is preferred for insulin and biologic formulations owing to its stability and low extractables profile. However, plastic cartridges are gaining traction, especially in applications requiring lightweight design, enhanced break resistance, and cost efficiency. The development of high-performance cyclic olefin polymers (COP) and cyclic olefin copolymers (COC) is expanding the scope of plastic cartridges in advanced drug delivery systems. As pharmaceutical companies seek differentiation in device design and patient usability, plastic cartridges are expected to witness accelerated adoption in the coming years.

Demand by Size

Based on size, the cartridges market is categorized into 1ml to 5ml, 5ml to 15ml, and 15ml to 30ml. The 1ml to 5ml segment holds a significant share, primarily due to its widespread use in insulin pens and other subcutaneous injectable therapies. These compact cartridges are optimized for precise dosing and patient convenience, making them highly suitable for diabetes management and other chronic conditions. The 5ml to 15ml segment is gaining momentum with the growing use of biologics and specialty pharmaceuticals that require moderate-volume delivery. Meanwhile, the 15ml to 30ml segment is finding niche applications in specialized therapies and certain veterinary or hospital-based uses. As drug pipelines increasingly feature biologics and combination therapies, demand across varied cartridge sizes is expected to remain robust.

Demand by Application

In terms of application, diabetes represents the dominant segment in the global cartridges market. The rising global burden of diabetes, particularly in emerging economies, is fueling the demand for insulin delivery systems, including reusable and disposable pen injectors. The convenience, accuracy, and patient compliance associated with cartridge-based pen systems have made them a preferred choice over traditional vial-and-syringe methods. The "others" segment, encompassing hormonal therapies, fertility treatments, and biologic drugs, is also expanding rapidly. As more injectable drugs transition to self-administration formats, cartridges are poised to capture a larger share of the injectable drug delivery ecosystem.

Market Driver

A key driver of the global cartridges market is the rising prevalence of diabetes worldwide, coupled with the growing adoption of pen-based insulin delivery systems. As healthcare systems emphasize home-based care and improved patient adherence, cartridge-integrated injectors offer a compelling value proposition in terms of safety, accuracy, and convenience.

Market Restraint

One significant restraint is the stringent regulatory and quality compliance requirements associated with pharmaceutical packaging components. Manufacturing cartridges demands high capital investment in cleanroom facilities, advanced inspection systems, and validation processes, which can limit market entry and exert pricing pressure on smaller manufacturers.

Demand by Region

North America remains a leading market, supported by high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of self-injection devices. The presence of major pharmaceutical companies and stringent regulatory standards further drives demand for high-quality, compliant cartridge systems. Europe follows closely, with robust demand stemming from established pharmaceutical manufacturing hubs and strong emphasis on patient safety and device innovation. Countries such as Germany and Switzerland serve as key centers for glass and specialty packaging production.

Asia-Pacific is emerging as the fastest-growing region, propelled by a rapidly expanding diabetic population, increasing healthcare access, and rising pharmaceutical manufacturing capabilities. Countries such as China and India are witnessing growing investments in injectable drug production, boosting demand for both glass and plastic cartridges. Additionally, cost-competitive manufacturing and expanding export activities are strengthening the region's position in the global supply chain.

Key Manufacturers

The major players operating in the market include Stevanato group, Nipro corporation, Gerreshimer AG, West Pharmaceutical services Inc., Schott AG, Transcoject GmbH, Shandong Medicinal Glass Co ltd, Datwlyer Holding Inc, Aptar Group Inc, Sonata Rubber

Overall, the global cartridges market is positioned for steady expansion, supported by innovation in materials, rising chronic disease prevalence, and the ongoing transformation of injectable drug delivery toward patient-centric solutions.

Table of Contents

1. Introduction

  • 1.1. Scope
  • 1.2. Market Coverage
    • 1.2.1. Material Type
    • 1.2.2. Size
    • 1.2.3. Applications
    • 1.2.4. Regions
    • 1.2.5. Countries
  • 1.3. Years Considered
    • 1.3.1. Historical - 2018 - 2023
    • 1.3.2. Base - 2024
    • 1.3.3. Forecast Period - 2025 - 2034
  • 1.4. Research Methodology
    • 1.4.1. Approach
    • 1.4.2. Research Methodology
    • 1.4.3. Prismane Consulting Market Models
    • 1.4.4. Assumptions & Limitations
    • 1.4.5. Abbreviations & Definitions
    • 1.4.6. Conversion Factors
    • 1.4.7. Data Sources

2. Market Synopsis

  • 2.1. Market Evolution
  • 2.2. Demand Overview
  • 2.3. Industry Structure
  • 2.4. Strategic Issues
  • 2.5. End-use Trends
  • 2.6. Growth Forecast

3. Economic & Energy Outlook

  • 3.1. GDP and Demographics
  • 3.2. Monetary & Fiscal Policies

4. Introduction to Cartridges and Market Overview

  • 4.1. Product Description
  • 4.2. Grades & Properties
  • 4.3. Raw Material
  • 4.4. Manufacturing Process
  • 4.5. Environmental Issues
  • 4.6. Value Chain
  • 4.7. Applications

5. Market Dynamics and Industry Trends

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunities
    • 5.1.4. Challenges

6. Global Cartridges Demand Analysis, By Material Type, By Size and By Application (Value) (2018-2034)

  • 6.1. Strategic Issues and COVID-19 Impact
  • 6.2. Demand Analysis and Forecast (2018 - 2034)
    • 6.2.1. Demand
    • 6.2.2. Demand Growth Rate (%)
    • 6.2.3. Driving Force Analysis
    • 6.2.4. Other Functional Ingredients
  • 6.3. Global Cartridges Market, By Material Type
    • 6.3.1. Glass
    • 6.3.2. Plastic
  • 6.4. Global Cartridges Market, By Size
    • 6.4.1. 1ml to 5ml
    • 6.4.2. 5ml to 15ml
    • 6.4.3. 15ml to 30ml
  • 6.5. Global Cartridges Market, By Application
    • 6.5.1. Diabetes
    • 6.5.2. Others

7. Demand Analysis and Market Review, By Region, By Country (Value), (2018- 2034)

  • 7.1. Strategic Issues and COVID-19 Impact
  • 7.2. Demand Analysis and Forecast (2018-2034)
  • 7.3. Demand Growth Rate (%)
  • 7.4. Cartridges Market, By Material Type
  • 7.5. Cartridges Market, By Size
  • 7.6. Cartridges Market, By Application
  • 7.7. North America
    • 7.7.1. USA
    • 7.7.2. Canada
    • 7.7.3. Mexico
  • 7.8. Western Europe
    • 7.8.1. Germany
    • 7.8.2. France
    • 7.8.3. Italy
    • 7.8.4. United Kingdom
    • 7.8.5. Spain
    • 7.8.6. Rest of Western Europe
  • 7.9. Central & Eastern Europe
    • 7.9.1. Russia
    • 7.9.2. Poland
    • 7.9.3. Turkey
    • 7.9.4. Rest of Central & Eastern Europe
  • 7.10. Asia-Pacific
    • 7.10.1. China
    • 7.10.2. Japan
    • 7.10.3. India
    • 7.10.4. South Korea
    • 7.10.5. ASEAN
    • 7.10.6. Rest of Asia-Pacific
  • 7.11. Central & South America
    • 7.11.1. Brazil
    • 7.11.2. Argentina
    • 7.11.3. Rest of Central & South America
  • 7.12. Middle East
    • 7.12.1. Saudi Arabia
    • 7.12.2. UAE
    • 7.12.3. Rest of Middle East
  • 7.13. Africa
    • 7.13.1. South Africa
    • 7.13.2. Rest of MEA

8. Pricing Analysis

9. Key Strategic Issues and Business Opportunity Assessment

  • 9.1. Market Attractiveness Assessment
  • 9.2. Prospective & Target Market Study

10. Strategic Recommendation & Suggestions

11. Company Analysis and Market Share Analysis

  • 11.1. Cartridges Manufacturers Profiles/ Company Analysis
    • 11.1.1. Basic Details
    • 11.1.2. Headquarter, Key Markets
    • 11.1.3. Ownership
    • 11.1.4. Company Financial
    • 11.1.5. Manufacturing Bases
    • 11.1.6. Global Turnover
    • 11.1.7. Total Employee
    • 11.1.8. Product Portfolio / Services / Solutions
    • 11.1.9. Key Business Strategies adopted and Prismane Consulting Overview
    • 11.1.10. Recent Developments
    • 11.1.11. Companies Covered
      • 11.1.11.1. Stevanato Group
      • 11.1.11.2. Nipro Corporation
      • 11.1.11.3. Gerreshimer AG
      • 11.1.11.4. West Pharmaceuticals Services Inc
      • 11.1.11.5. Schott AG
      • 11.1.11.6. Transcoject GmbH
      • 11.1.11.7. Shandong Medical Glass Co ltd
      • 11.1.11.8. Datwlyer Holding Inc
      • 11.1.11.9. Aptar Group Inc
      • 11.1.11.10. Sonata Rubber
      • 11.1.11.11. Other Manufacturers

12. Note: This section includes company information, company financials, manufacturing bases, and operating regions. Company financials have been mentioned only for those companies where financials were available in SEC Filings, annual reports, or company websites. All the reported financials in this report are in U.S. Dollars. Financials reported in other currencies have been converted using average currency conversion rates. Company profiles may include manufacturers, suppliers, and distributors.

13. Appendices

  • 13.1. Demand- Regions
  • 13.2. Demand- Countries